August 30, 2022 Active cannabis consumers fared better against COVID-19 than non-consumers according to preliminary research published this month in the Journal of Cannabis Research.
A preliminary study published this month in the Journal of Cannabis Research suggests that active cannabis consumers diagnosed with COVID-19 had better clinical outcomes than non-cannabis consumers, including the decreased need for ICU admission or mechanical ventilation.
However, the researchers warn that the study results “need to be interpreted with caution given the limitations of a retrospective analysis.” The study included two hospitals in the Los Angeles, California area, and out of the 1,831 covid patients in the study, just 69 patients reported active cannabis use, which was 4% of the total patients.
